Brazil’s Ministry of Health
Brazil’s Ministry of Health
Brazil’s Ministry of Health incorporated iptacopan into the Sistema Único de Saúde (SUS) for paroxysmal nocturnal hemoglobinuria (PNH) patients previously treated with a C5 inhibitor and with hemoglobin below 10 …
Brazil’s federal health ministry began dispensing nine new cancer drugs through the public Sistema Único de Saúde (SUS) network this week, for more than 116,000 patients, and expects all 23 …
Brazil’s public health system (SUS) has added extended-release lithium on tolerability and adherence grounds, and the Dominican health-insurance regulator, the Superintendency of Health and Occupational Risks (SISALRIL), is studying wider …
A committee of Conitec, Brazil’s health technology assessment body, provisionally recommended ViiV’s HIV-prevention injection at its proposed price of about R$6,660 a year, while Brazil offered Gilead roughly a third …
Brazil’s Health Ministry has formally asked Conitec to evaluate semaglutide and liraglutide for public-system coverage, opening a process that could reshape the country’s obesity-drug market.
Anvisa cancelled Elevidys’s conditional registration on August 24 at Roche’s request, citing insufficient safety and efficacy data — ending Brazilian access to the country’s most expensive approved drug.
Law 15.385/2026 mandates SUS incorporation of CONITEC-approved oncology drugs while a Fiocruz-MSD partnership delivers 100% domestically produced pembrolizumab, reducing Brazil’s import dependence for a flagship immunotherapy.
Brazil’s Ministry of Health and ONA have launched the country’s first accreditation manual for digital health, telemedicine, and telehealth services, establishing a formal quality and safety certification pathway for public …
You must be logged in to post a comment.